| Sandoz Pharmaceuticals AG - Afqlir 40 mg/ml, Injektionslösung in einer Fertigspritze | | 70126 | | 01 | | Afqlir 40 mg/ml | | Injektionslösung in einer Fertigspritze | | S01LA05 | | Aflibercept | | 25.09.2025 | | |
| | Composition | | afliberceptum 2 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 20, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 50 µl corresp. natrium 1.73 µg. | | Packungsbestandteile | | Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Afliberceptum | 2mg / 50µl |
| | BAG: Active Agent | Dose |
|---|
| Afliberceptum | 2 mg |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Histidin Hydrochloride Monohydrate | | Histidine | | Sodium Hydroxide | | Polysorbatum 20 | | Trehalosum Dihydricum |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 417.33 | 478.45 | B | SL | No |
|
|
